Accumulation of apolipoproteins in the regenerating and remyelinating mammalian peripheral nerve. Identification of apolipoprotein D, apolipoprotein A-IV, apolipoprotein E, and apolipoprotein A-I.
In this report, we have identified two apolipoproteins (apo), apoD and apoA-IV, that, together with the previously identified apoA-I and apoE, accumulate in the regenerating peripheral nerve. These four apolipoproteins were identified in regenerating rat sciatic nerves by their molecular weights, their isoelectric points, and their recognition by specific antibodies. Antibodies were also used to document the changing concentrations of these apolipoproteins in homogenates of regenerating sciatic nerves collected 1 day to 6 weeks after a denervating crush injury. By 3 weeks after injury, at their peak accumulation, apoA-IV and apoA-I had increased 14- and 26-fold, respectively, relative to their concentrations in the normal nerve. Apolipoproteins D and E, in contrast, increased over 500- and 250-fold, respectively, by 3 weeks. These same apolipoproteins also accumulated in the regenerating sciatic nerves of two other species, the rabbit and the marmoset monkey. Immunocytochemistry showed that apoD was produced by astrocytes and oligodendrocytes in the normal central nervous system, and by neurolemmal or fibroblastic cells in the normal peripheral nervous system. Metabolic labeling of both apoD and apoE by [35S]methionine during an in vitro incubation of regenerating rat sciatic nerve segments confirmed that these apolipoproteins are synthesized by the nerve. Neither apoA-IV nor apoA-I was metabolically labeled, however, suggesting that they enter the nerve from the plasma. The results from this study provide evidence that several different apolipoproteins from various sources may play a role in lipid transport within neural tissues.
Boyles
J K
JK
Gladstone Foundation Laboratories for Cardiovascular Disease, Department of Pathology, University of California, San Francisco 94140-0608.
Notterpek
L M
LM
Anderson
L J
LJ
D000818:Animals; D016632:Apolipoprotein A-I; D001053:Apolipoproteins / Q000096:biosynthesis* / Q000302:isolation & purification; D001054:Apolipoproteins A / Q000096:biosynthesis* / Q000302:isolation & purification; D053399:Apolipoproteins D; D001057:Apolipoproteins E / Q000096:biosynthesis* / Q000302:isolation & purification; D001253:Astrocytes / Q000378:metabolism / Q000648:ultrastructure; D007150:Immunohistochemistry; D008075:Lipoproteins, HDL / Q000096:biosynthesis; D008297:Male; D016253:Microscopy, Immunoelectron; D008970:Molecular Weight; D009186:Myelin Sheath / Q000502:physiology* / Q000648:ultrastructure; D009416:Nerve Regeneration; D051381:Rats; D011919:Rats, Inbred Strains; D012584:Sciatic Nerve / Q000378:metabolism / Q000502:physiology* / Q000648:ultrastructure; D013116:Spinal Cord / Q000378:metabolism / Q000502:physiology / Q000648:ultrastructure
D016632:Apolipoprotein A-I; D001053:Apolipoproteins; D001054:Apolipoproteins A; D053399:Apolipoproteins D; D001057:Apolipoproteins E; D008075:Lipoproteins, HDL; C022205:apolipoprotein A-IV